Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 20 of 20 entries
Sorted by: Best Match Show Resources per page
Reply: To PMID 25631192.

Annals of neurology

Tell-Martí G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S.
PMID: 25913870
Ann Neurol. 2015 Jul;78(1):153-4. doi: 10.1002/ana.24418. Epub 2015 May 25.

No abstract available.

Cite
Tell-Martí G, Puig-Butille JA, Potrony M, et al. Reply: To PMID 25631192. Ann Neurol. 2015;78(1):153-4doi: 10.1002/ana.24418.
Tell-Martí, G., Puig-Butille, J. A., Potrony, M., Badenas, C., Milà, M., Malvehy, J., Martí, M. J., Ezquerra, M., Fernández-Santiago, R., & Puig, S. (2015). Reply: To PMID 25631192. Annals of neurology, 78(1), 153-4. https://doi.org/10.1002/ana.24418
Tell-Martí, Gemma, et al. "Reply: To PMID 25631192." Annals of neurology vol. 78,1 (2015): 153-4. doi: https://doi.org/10.1002/ana.24418
Tell-Martí G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S. Reply: To PMID 25631192. Ann Neurol. 2015 Jul;78(1):153-4. doi: 10.1002/ana.24418. Epub 2015 May 25. PMID: 25913870.
Copy Download .nbib Format: NLM
Is the MC1R variant p.R160W associated with Parkinson's?.

Annals of neurology

Lubbe SJ, Escott-Price V, Brice A, Gasser T, Hardy J, Heutink P, Sharma M, Wood NW, Nalls M, Singleton AB, Williams NM, Morris HR.
PMID: 26389967
Ann Neurol. 2016 Jan;79(1):159-61. doi: 10.1002/ana.24527. Epub 2015 Dec 12.

No abstract available.

Cite
Lubbe SJ, Escott-Price V, Brice A, et al. Is the MC1R variant p.R160W associated with Parkinson's?. Ann Neurol. 2015;79(1):159-61doi: 10.1002/ana.24527.
Lubbe, S. J., Escott-Price, V., Brice, A., Gasser, T., Hardy, J., Heutink, P., Sharma, M., Wood, N. W., Nalls, M., Singleton, A. B., Williams, N. M., Morris, H. R. (2016). Is the MC1R variant p.R160W associated with Parkinson's?. Annals of neurology, 79(1), 159-61. https://doi.org/10.1002/ana.24527
Lubbe, Steven J, et al. "Is the MC1R variant p.R160W associated with Parkinson's?." Annals of neurology vol. 79,1 (2016): 159-61. doi: https://doi.org/10.1002/ana.24527
Lubbe SJ, Escott-Price V, Brice A, Gasser T, Hardy J, Heutink P, Sharma M, Wood NW, Nalls M, Singleton AB, Williams NM, Morris HR. Is the MC1R variant p.R160W associated with Parkinson's?. Ann Neurol. 2016 Jan;79(1):159-61. doi: 10.1002/ana.24527. Epub 2015 Dec 12. PMID: 26389967; PMCID: PMC4738170.
Copy Download .nbib Format: NLM
Nonsynonymous variants in MC1R are rare in Chinese Parkinson disease cases.

Annals of neurology

Foo JN, Zhao Y, Liu J, Tan EK.
PMID: 25894970
Ann Neurol. 2015 Jul;78(1):152-3. doi: 10.1002/ana.24419. Epub 2015 May 25.

No abstract available.

Cite
Foo JN, Zhao Y, Liu J, et al. Nonsynonymous variants in MC1R are rare in Chinese Parkinson disease cases. Ann Neurol. 2015;78(1):152-3doi: 10.1002/ana.24419.
Foo, J. N., Zhao, Y., Liu, J., & Tan, E. K. (2015). Nonsynonymous variants in MC1R are rare in Chinese Parkinson disease cases. Annals of neurology, 78(1), 152-3. https://doi.org/10.1002/ana.24419
Foo, Jia Nee, et al. "Nonsynonymous variants in MC1R are rare in Chinese Parkinson disease cases." Annals of neurology vol. 78,1 (2015): 152-3. doi: https://doi.org/10.1002/ana.24419
Foo JN, Zhao Y, Liu J, Tan EK. Nonsynonymous variants in MC1R are rare in Chinese Parkinson disease cases. Ann Neurol. 2015 Jul;78(1):152-3. doi: 10.1002/ana.24419. Epub 2015 May 25. PMID: 25894970.
Copy Download .nbib Format: NLM
Epigenetic marks in melanoma.

Pigment cell & melanoma research

Richards HW, Medrano EE.
PMID: 19040501
Pigment Cell Melanoma Res. 2009 Feb;22(1):14-29. doi: 10.1111/j.1755-148X.2008.00534.x. Epub 2008 Nov 27.

Melanoma is a highly heterogeneous cancer that comes in different flavors (lentigo maligna melanoma, superficial spreading melanoma, nodular melanoma, acral lentiginous/mucosal melanoma and other less common subtypes including malignant cellular blue nevus, desmoplastic melanoma, nevoid melanoma, and animal-type melanoma)...

Cite
Richards HW, Medrano EE. Epigenetic marks in melanoma. Pigment Cell Melanoma Res. 2008;22(1):14-29doi: 10.1111/j.1755-148X.2008.00534.x.
Richards, H. W., & Medrano, E. E. (2009). Epigenetic marks in melanoma. Pigment cell & melanoma research, 22(1), 14-29. https://doi.org/10.1111/j.1755-148X.2008.00534.x
Richards, Hunter W, and Medrano, Estela E. "Epigenetic marks in melanoma." Pigment cell & melanoma research vol. 22,1 (2009): 14-29. doi: https://doi.org/10.1111/j.1755-148X.2008.00534.x
Richards HW, Medrano EE. Epigenetic marks in melanoma. Pigment Cell Melanoma Res. 2009 Feb;22(1):14-29. doi: 10.1111/j.1755-148X.2008.00534.x. Epub 2008 Nov 27. PMID: 19040501.
Copy Download .nbib Format: NLM
Genetic aspects of malignant melanoma.

A.M.A. archives of dermatology and syphilology

CAWLEY EP, KRUSE WT, PINKUS HK.
PMID: 14902112
AMA Arch Derm Syphilol. 1952 Apr;65(4):440-50. doi: 10.1001/archderm.1952.01530230064006.

No abstract available.

Cite
CAWLEY EP, KRUSE WT, PINKUS HK. Genetic aspects of malignant melanoma. AMA Arch Derm Syphilol. 1952;65(4):440-50doi: 10.1001/archderm.1952.01530230064006.
CAWLEY, E. P., KRUSE, W. T., & PINKUS, H. K. (1952). Genetic aspects of malignant melanoma. A.M.A. archives of dermatology and syphilology, 65(4), 440-50. https://doi.org/10.1001/archderm.1952.01530230064006
CAWLEY, E P, et al. "Genetic aspects of malignant melanoma." A.M.A. archives of dermatology and syphilology vol. 65,4 (1952): 440-50. doi: https://doi.org/10.1001/archderm.1952.01530230064006
CAWLEY EP, KRUSE WT, PINKUS HK. Genetic aspects of malignant melanoma. AMA Arch Derm Syphilol. 1952 Apr;65(4):440-50. doi: 10.1001/archderm.1952.01530230064006. PMID: 14902112.
Copy Download .nbib Format: NLM
MicroRNAs in cancer: lessons from melanoma.

Current pharmaceutical design

Greenberg E, Nemlich Y, Markel G.
PMID: 24479804
Curr Pharm Des. 2014;20(33):5246-59. doi: 10.2174/1381612820666140128210105.

Melanoma is a high-grade, poorly differentiated malignant tumor of pigment-producing cells (melanocytes), accounting for more than 70% of the skin cancer related deaths. Although new lines of targeted therapy and immunotherapy were introduced lately, durable responses are not common...

Cite
Greenberg E, Nemlich Y, Markel G. MicroRNAs in cancer: lessons from melanoma. Curr Pharm Des. 2014;20(33):5246-59doi: 10.2174/1381612820666140128210105.
Greenberg, E., Nemlich, Y., & Markel, G. (2014). MicroRNAs in cancer: lessons from melanoma. Current pharmaceutical design, 20(33), 5246-59. https://doi.org/10.2174/1381612820666140128210105
Greenberg, Eyal, et al. "MicroRNAs in cancer: lessons from melanoma." Current pharmaceutical design vol. 20,33 (2014): 5246-59. doi: https://doi.org/10.2174/1381612820666140128210105
Greenberg E, Nemlich Y, Markel G. MicroRNAs in cancer: lessons from melanoma. Curr Pharm Des. 2014;20(33):5246-59. doi: 10.2174/1381612820666140128210105. PMID: 24479804.
Copy Download .nbib Format: NLM
CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing.

Genome biology

Jiang Y, Wang R, Urrutia E, Anastopoulos IN, Nathanson KL, Zhang NR.
PMID: 30477554
Genome Biol. 2018 Nov 26;19(1):202. doi: 10.1186/s13059-018-1578-y.

High-throughput DNA sequencing enables detection of copy number variations (CNVs) on the genome-wide scale with finer resolution compared to array-based methods but suffers from biases and artifacts that lead to false discoveries and low sensitivity. We describe CODEX2, as...

Cite
Jiang Y, Wang R, Urrutia E, et al. CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing. Genome Biol. 2018;19(1):202doi: 10.1186/s13059-018-1578-y.
Jiang, Y., Wang, R., Urrutia, E., Anastopoulos, I. N., Nathanson, K. L., & Zhang, N. R. (2018). CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing. Genome biology, 19(1), 202. https://doi.org/10.1186/s13059-018-1578-y
Jiang, Yuchao, et al. "CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing." Genome biology vol. 19,1 (2018): 202. doi: https://doi.org/10.1186/s13059-018-1578-y
Jiang Y, Wang R, Urrutia E, Anastopoulos IN, Nathanson KL, Zhang NR. CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing. Genome Biol. 2018 Nov 26;19(1):202. doi: 10.1186/s13059-018-1578-y. PMID: 30477554; PMCID: PMC6260772.
Copy Download .nbib Format: NLM
Targeting the Microbiome to Overcome Resistance.

Cancer cell

Simpson RC, Shanahan E, Scolyer RA, Long GV.
PMID: 33561397
Cancer Cell. 2021 Feb 08;39(2):151-153. doi: 10.1016/j.ccell.2021.01.016.

Immune checkpoint inhibition has revolutionized the treatment of many cancers, including melanoma. However, primary and acquired resistance remain key challenges for the field. Promising results from a phase I clinical trial recently published in Science highlight the potential of...

Cite
Simpson RC, Shanahan E, Scolyer RA, et al. Targeting the Microbiome to Overcome Resistance. Cancer Cell. 2021;39(2):151-153doi: 10.1016/j.ccell.2021.01.016.
Simpson, R. C., Shanahan, E., Scolyer, R. A., & Long, G. V. (2021). Targeting the Microbiome to Overcome Resistance. Cancer cell, 39(2), 151-153. https://doi.org/10.1016/j.ccell.2021.01.016
Simpson, Rebecca C, et al. "Targeting the Microbiome to Overcome Resistance." Cancer cell vol. 39,2 (2021): 151-153. doi: https://doi.org/10.1016/j.ccell.2021.01.016
Simpson RC, Shanahan E, Scolyer RA, Long GV. Targeting the Microbiome to Overcome Resistance. Cancer Cell. 2021 Feb 08;39(2):151-153. doi: 10.1016/j.ccell.2021.01.016. PMID: 33561397.
Copy Download .nbib Format: NLM
Showing 13 to 20 of 20 entries